Serveur d'exploration COVID et hydrochloroquine - Exploration (Accueil)

Index « Keywords » - entrée « Drug Repositioning (MeSH) »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Drug Prescriptions (statistics & numerical data) < Drug Repositioning (MeSH) < Drug Repositioning (economics)  Facettes :

List of bibliographic references indexed by Drug Repositioning (MeSH)

Number of relevant bibliographic references: 101.
[0-20] [0 - 20][0 - 50][20-40]
Ident.Authors (with country if any)Title
000020 (2021) Fabio Cruciani [Italie] ; Laura Amato [Italie] ; Franco De Crescenzo ; Zuzana Mitrova [Italie] ; Rosella Saulle [Italie] ; Simona Vecchi [Italie] ; Marina Davoli [Italie][The praise of uncertainty: a systematic living review to evaluate the efficacy and safety of drug treatments for patients with covid-19.]
000044 (2021) Jason D. Goldman [États-Unis] ; George Diaz [États-Unis] ; Walter J. Urba [États-Unis]Use of hydroxychloroquine in combination with azithromycin for patients with COVID-19 is not supported by recent literature.
000055 (2021) Tuan V. Nguyen [Australie]Uncertain effects of hydroxychloroquine and azithromycin on SARS-Cov-2 viral load.
000075 (2021) Sawsan Elgohary [Égypte] ; Aya A. Elkhodiry [Égypte] ; Nada S. Amin [Égypte] ; Ulrike Stein [Allemagne] ; Hend M. El Tayebi [Égypte]Thymoquinone: A Tie-Breaker in SARS-CoV2-Infected Cancer Patients?
000150 (2021) Philippe Gautret [France] ; Stéphane Honoré [France] ; Jean-Christophe Lagier [France] ; Didier Raoult [France]Safety profile of hydroxychloroquine and azithromycin combined treatment in COVID-19 patients.
000188 (2021) Veronique Michaud [États-Unis, Canada] ; Pamela Dow [États-Unis] ; Sweilem B. Al Rihani [États-Unis] ; Malavika Deodhar [États-Unis] ; Meghan Arwood [États-Unis] ; Brian Cicali [États-Unis] ; Jacques Turgeon [États-Unis, Canada]Risk Assessment of Drug-Induced Long QT Syndrome for Some COVID-19 Repurposed Drugs.
000190 (2021) Dingzhong Li [République populaire de Chine] ; Jianbing Hu [République populaire de Chine] ; Dian Li [République populaire de Chine] ; Weijun Yang [République populaire de Chine] ; Shuang-Feng Yin [République populaire de Chine] ; Renhua Qiu [République populaire de Chine]Reviews on Biological Activity, Clinical Trial and Synthesis Progress of Small Molecules for the Treatment of COVID-19.
000204 (2021) Evellyn Claudia Wietzikoski Lovato [Brésil] ; Lorena Neris Barboza [Brésil] ; Samantha Wietzikoski [Brésil] ; Amanda Nascimento Vasques De Souza [Brésil] ; Pablo Alvarez Auth [Brésil] ; Arquimedes Gasparotto Junior [Brésil] ; Francislaine Aparecida Dos Reis Lívero [Brésil]Repurposing Drugs for the Management of Patients with Confirmed Coronavirus Disease 2019 (COVID-19).
000218 (2021) Marcelo Rodrigues Dos Santos [Brésil]Referring to the study: Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open label non-randomized clinical trial.
000221 (2021) Seongman Bae [Corée du Sud] ; Byeongzu Ghang [Corée du Sud] ; Ye-Jee Kim [Corée du Sud] ; Joon Seo Lim [Corée du Sud] ; Sung-Cheol Yun [Corée du Sud] ; Yong-Gil Kim [Corée du Sud] ; Sang-Oh Lee [Corée du Sud] ; Sung-Han Kim [Corée du Sud]Recent Hydroxychloroquine Use Is Not Significantly Associated with Positive PCR Results for SARS-CoV-2: A Nationwide Observational Study in South Korea.
000265 (2021) Gayathri Baburaj [Inde] ; Levin Thomas [Inde] ; Mahadev Rao [Inde]Potential Drug Interactions of Repurposed COVID-19 Drugs with Lung Cancer Pharmacotherapies.
000294 (2021) Sanjay Kumar Mishra [Inde] ; Timir Tripathi [Inde]One year update on the COVID-19 pandemic: Where are we now?
000307 (2021) Shweta A. More [Inde] ; Akshay S. Patil [États-Unis] ; Nikhil S. Sakle [Inde] ; Santosh N. Mokale [Inde]Network analysis and molecular mapping for SARS-CoV-2 to reveal drug targets and repurposing of clinically developed drugs.
000317 (2021) Masashi Ohe [Japon] ; Ken Furuya [Japon] ; Houman Goudarzi [Japon]Multidrug treatment for COVID-19.
000326 (2021) C N Prashantha [Inde] ; K. Gouthami [Inde] ; L. Lavanya [Inde] ; Sivaramireddy Bhavanam [Inde] ; Ajay Jakhar [Inde] ; R G Shakthiraju [Inde] ; V. Suraj [Inde] ; K V Sahana [Inde] ; H S Sujana [Inde] ; N M Guruprasad [Inde] ; R. Ramachandra [Inde]Molecular screening of antimalarial, antiviral, anti-inflammatory and HIV protease inhibitors against spike glycoprotein of coronavirus.
000338 (2021) Florence Rodgers [Royaume-Uni] ; Toby Pepperrell [Royaume-Uni] ; Sarai Keestra [Pays-Bas, Royaume-Uni] ; Victoria Pilkington [Royaume-Uni]Missing clinical trial data: the evidence gap in primary data for potential COVID-19 drugs.
000352 (2021) Nicolas De Schryver [Belgique] ; Nicolas Serck [Belgique] ; Marco Vinetti [Belgique] ; Ludovic Gérard [Belgique]Low-dose hydroxychloroquine therapy and lower mortality in hospitalized patients with COVID-19: association does not mean causality.
000356 (2021) Mohamed O. Saad [Qatar]Letter to the editor about "Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial".
000369 (2021) Philippe Colson [France] ; Bernard La Scola [France] ; Jean-Christophe Lagier [France] ; Philippe Gautret [France] ; Didier Raoult [France]Interpretation of SARS-CoV-2 PCR results for the diagnosis of COVID-19.
000388 (2021) Iqbal Hussain [Arabie saoudite] ; Afzal Hussain [Arabie saoudite] ; Mohamed F. Alajmi [Arabie saoudite] ; Md Tabish Rehman [Arabie saoudite] ; Samira Amir [Arabie saoudite]Impact of repurposed drugs on the symptomatic COVID-19 patients.
000427 (2021) Marco Infante [Italie, États-Unis] ; Camillo Ricordi [États-Unis] ; Rodolfo Alejandro [États-Unis] ; Massimiliano Caprio [Italie] ; Andrea Fabbri [Italie]Hydroxychloroquine in the COVID-19 pandemic era: in pursuit of a rational use for prophylaxis of SARS-CoV-2 infection.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidChloroV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i -k "Drug Repositioning (MeSH)" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i  \
                -Sk "Drug Repositioning (MeSH)" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    CovidChloroV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    Drug Repositioning (MeSH)
}}

Wicri

This area was generated with Dilib version V0.6.38.
Data generation: Sat May 22 17:02:32 2021. Site generation: Sat May 22 17:06:52 2021